APA (7th ed.) Citation

M, I., S, T., MK, A., A, Z., FA, K., H, A., . . . SA, W. (2026). Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Systematic Review and Meta-Analysis. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 32, 10760296261422490. https://doi.org/10.1177/10760296261422490

Chicago Style (17th ed.) Citation

M, Ibrahim, et al. "Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Systematic Review and Meta-Analysis." Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 32 (2026): 10760296261422490. https://doi.org/10.1177/10760296261422490.

MLA (9th ed.) Citation

M, Ibrahim, et al. "Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Systematic Review and Meta-Analysis." Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, vol. 32, 2026, p. 10760296261422490, https://doi.org/10.1177/10760296261422490.